Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$774,700
-$1,812,439 QoQ
Shares Held
82,240
-78.6% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 263 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Dec 31, 2025CallValue
$3,243,744
CallShares
482,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. NVAX ranks #135 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in NVAX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,700 | 82,240 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $3,243,744 | 482,700 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $2,587,139 | 384,991 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,104,961 | 358,127 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $6,175,641 | 712,300 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $300,849 | 34,700 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $3,950,100 | 627,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $497,700 | 79,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $862,145 | 134,500 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $235,247 | 36,700 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $463,908 | 57,700 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $1,380,468 | 171,700 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $1,646,952 | 130,400 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $1,044,450 | 82,500 | Call | Sole | 2024-08-14 | |
| 2023-09-30 | $9,991,265 | 1,380,009 | Shares | Sole | 2023-11-14 | |
| 2022-09-30 | $357,320 | 19,633 | Shares | Other | 2022-11-15 | |
| 2022-03-31 | $1,362,525 | 18,500 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $321,629 | 4,367 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $7,765,210 | 37,457 | Shares | Sole | 2021-12-01 | |
| 2021-06-30 | $17,986,053 | 84,716 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,457,023 | 46,644 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,865,695 | 25,699 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||